Dr. Reddy’s forays into India’s biosimilar immuno-oncology market, launches Nivorz
Dr. Reddy’s Laboratories on Tuesday said it is foraying into the biosimilar immuno-oncology therapy segment in India with the launch of Nivorz, a biosimilar of Bristol Myers Squibb’s Opdivo (nivolumab). The biosimilar has been developed and manufactured entirely in-house at its biologics facility in Bachupally, Hyderabad. The launch reflects the company’s end-to-end capabilities across the…
Read More “Dr. Reddy’s forays into India’s biosimilar immuno-oncology market, launches Nivorz” »
